North America is home to some incredible conferences and conventions surrounding cancer research, therapy development and biotech investments. With the strength of the American biotech and life sciences industries, several of these lineage conferences have been around for decades. Many CEOs, scientists and clinical experts speak at the various events and chair panels to create discussions on various topics that are currently of large importance in medicine. Each quarter, we attend or keep our eye on at least a few of these events. For March and April, these are 4 of the upcoming conferences that we are interested in:
SAN DIEGO – March 14, 2013 — OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that Punit Dhillon, President and CEO, will present at the 25th Annual Roth Conference at the Ritz-Carlton, Laguna Niguel in Dana Point, California, on Tuesday, March 19th at 8:00AM Pacific Time.
Mr. Dhillon will provide an overview of the Company and its milestones during the presentation, and will be conducting one-on-one meetings with investors who are registered to attend the conference.
The presentation will be webcast live. To access the webcast, please visit http://wsw.com/webcast/roth27/oncs/. The webcast will be archived for 90 days.
About the Annual Roth Conference
The 25th Annual Roth Conference is designed to provide investors with a unique opportunity to gain insight into emerging growth companies across a variety of sectors, including Business Services, Consumer, Cleantech, Industrials & Resources, Healthcare, Metals & Mining and Technology & Media.
The event is one of the largest of its kind in the U.S. It will feature presentations from hundreds of growth companies, expert panels and thousands of management one-on-one/small group meetings. To find out more, visit www.roth.com.